Skip to main content
Top
Published in: Annals of Surgical Oncology 4/2011

01-04-2011 | Hepatobiliary Tumors

Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases

Authors: Michael D’Angelica, MD, FACS, Peter Kornprat, MD, Mithat Gonen, PhD, Ronald P. DeMatteo, MD, FACS, Yuman Fong, MD, FACS, Leslie H. Blumgart, MD, FACS, FRCS, William R. Jarnagin, MD, FACS

Published in: Annals of Surgical Oncology | Issue 4/2011

Login to get access

Abstract

Background

Despite improvements in surgery and chemotherapy, most patients develop recurrence after hepatectomy for metastatic colorectal cancer. Data are lacking on the effect of these patterns on outcome.

Methods

A retrospective review of a prospectively maintained hepatobiliary database was performed. Pattern and timing of recurrence and outcome after recurrence were analyzed. Univariate and multivariate analyses of factors associated with outcome after recurrence were carried out.

Results

From January 1997 through May 2003, a total of 733 patients underwent hepatectomy for colorectal metastases. Of these, 637 patients (87%) were included in the analysis, and in 393 patients (62%), recurrence was documented at the time of last follow-up. Initial recurrence patterns included the following: liver only in 120 patients (31%), lung only in 107 (27%), other single sites in 49 (12%), and multiple sites in 117 (30%). Recurrence occurred within 2 years of hepatectomy in 75% of patients and after 3 years in 11%. Margins at hepatectomy, recurrence pattern, resected recurrence, and disease-free interval from time of colectomy to hepatic metastasis and from time of hepatectomy to recurrence were independently associated with survival as measured from the time of recurrence. Recurrence in the lung, resected recurrence, and time to recurrence after hepatectomy were associated with prolonged survival as measured from the time of hepatectomy and the time of recurrence.

Conclusions

The timing and pattern of recurrence after hepatic resection for metastatic colorectal cancer are important predictors of long-term survival.
Literature
1.
2.
go back to reference Fong Y, Fortner J, Sun R, et al. Clinical Score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–30.PubMedCrossRef Fong Y, Fortner J, Sun R, et al. Clinical Score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309–30.PubMedCrossRef
3.
go back to reference Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71.PubMedCrossRef Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59–71.PubMedCrossRef
4.
go back to reference Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–62.PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer. 1996;77:1254–62.PubMedCrossRef
5.
go back to reference Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–66.PubMedCrossRef Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235:759–66.PubMedCrossRef
6.
7.
go back to reference Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–84.PubMed Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery. 1986;100:278–84.PubMed
8.
go back to reference Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938–46.PubMed Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938–46.PubMed
9.
go back to reference Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 1987;205:264–70.PubMedCrossRef Bozzetti F, Doci R, Bignami P, et al. Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg. 1987;205:264–70.PubMedCrossRef
10.
go back to reference Topal B, Kaufmann L, Aerts R, et al. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol. 2003;29:248–53.PubMedCrossRef Topal B, Kaufmann L, Aerts R, et al. Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol. 2003;29:248–53.PubMedCrossRef
11.
go back to reference Metcalfe M, Mann C, Mullin E, et al. Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg. 2005;75:524–7.PubMedCrossRef Metcalfe M, Mann C, Mullin E, et al. Detecting curable disease following hepatectomy for colorectal metastases. ANZ J Surg. 2005;75:524–7.PubMedCrossRef
12.
go back to reference Ueno H, Mochizuki H, Hashiguchi Y, et al. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg. 2004;91:327–33.PubMedCrossRef Ueno H, Mochizuki H, Hashiguchi Y, et al. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg. 2004;91:327–33.PubMedCrossRef
13.
go back to reference Mutsaerts ELAR, van Ruth S, Zoetmulder FAN, et al. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg. 2005;9:178–86.PubMedCrossRef Mutsaerts ELAR, van Ruth S, Zoetmulder FAN, et al. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. J Gastrointest Surg. 2005;9:178–86.PubMedCrossRef
14.
go back to reference Takahashi S, Inoue K, Konoshi M, et al. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery. 2003;133:627–34.PubMedCrossRef Takahashi S, Inoue K, Konoshi M, et al. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery. 2003;133:627–34.PubMedCrossRef
15.
go back to reference Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer. A bi-institutional analysis. Ann Surg. 2002;235:863–71.PubMedCrossRef Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer. A bi-institutional analysis. Ann Surg. 2002;235:863–71.PubMedCrossRef
16.
go back to reference Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51–62.PubMedCrossRef Adam R, Bismuth H, Castaing D, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 1997;225:51–62.PubMedCrossRef
17.
go back to reference Headrick JR, Miller DL, Nagorney DM, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975–9.PubMedCrossRef Headrick JR, Miller DL, Nagorney DM, et al. Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg. 2001;71:975–9.PubMedCrossRef
18.
go back to reference Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection. Ann Surg. 2002;236:397–407.PubMedCrossRef Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection. Ann Surg. 2002;236:397–407.PubMedCrossRef
19.
go back to reference Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet. 1957;105:310–8.PubMed Goldsmith NA, Woodburne RT. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet. 1957;105:310–8.PubMed
20.
go back to reference Hohenberger P, Schlag P, Schwarz V, et al. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol. 1990;44:245–51.PubMedCrossRef Hohenberger P, Schlag P, Schwarz V, et al. Tumor recurrence and options for further treatment after resection of liver metastases in patients with colorectal cancer. J Surg Oncol. 1990;44:245–51.PubMedCrossRef
21.
go back to reference Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.PubMedCrossRef Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715–24.PubMedCrossRef
22.
go back to reference Cady B, Jenkins RL, Steele GD, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566–71.PubMedCrossRef Cady B, Jenkins RL, Steele GD, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566–71.PubMedCrossRef
23.
go back to reference Yamada H, Kondo S, Okushiba S, et al. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg. 2001;25:1129–33.PubMedCrossRef Yamada H, Kondo S, Okushiba S, et al. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases. World J Surg. 2001;25:1129–33.PubMedCrossRef
24.
go back to reference Tanaka T, Shimada H, Fujii Y, et al. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg. 2004;389:371–9.PubMedCrossRef Tanaka T, Shimada H, Fujii Y, et al. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Langenbecks Arch Surg. 2004;389:371–9.PubMedCrossRef
25.
go back to reference Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039–48.PubMedCrossRef Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 1999;341:2039–48.PubMedCrossRef
26.
go back to reference Weitz J, Koch M, Kienle P, et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg. 2000;232:66–72.PubMedCrossRef Weitz J, Koch M, Kienle P, et al. Detection of hematogenic tumor cell dissemination in patients undergoing resection of liver metastases of colorectal cancer. Ann Surg. 2000;232:66–72.PubMedCrossRef
27.
go back to reference Patel H, Le Marer N, Wharton RQ, et al. Clearence of circulating tumor cells after excision of primary colorectal cancer. Ann Surg. 2002;235;226–31.PubMedCrossRef Patel H, Le Marer N, Wharton RQ, et al. Clearence of circulating tumor cells after excision of primary colorectal cancer. Ann Surg. 2002;235;226–31.PubMedCrossRef
Metadata
Title
Effect on Outcome of Recurrence Patterns After Hepatectomy for Colorectal Metastases
Authors
Michael D’Angelica, MD, FACS
Peter Kornprat, MD
Mithat Gonen, PhD
Ronald P. DeMatteo, MD, FACS
Yuman Fong, MD, FACS
Leslie H. Blumgart, MD, FACS, FRCS
William R. Jarnagin, MD, FACS
Publication date
01-04-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 4/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1409-1

Other articles of this Issue 4/2011

Annals of Surgical Oncology 4/2011 Go to the issue